Eric Schadt is Mount Sinai Professor in Predictive Health and Computational Biology at the Icahn School of Medicine in New York City. He is also founder and chief executive officer of the predictive health company Sema4.
Eric Schadt
Professor
Icahn School of Medicine at Mount Sinai
From this contributor
Counseling can ease shock of unexpected genetic results
The best way to deliver surprises from genetic findings is to provide adequate information and counseling alongside the results.
Counseling can ease shock of unexpected genetic results
By
Eric Schadt
23 October 2018 | 6 min read
Explore more from The Transmitter
Betting blind on AI and the scientific mind
If the struggle to articulate an idea is part of how you come to understand it, then tools that bypass that struggle might degrade your capacity for the kind of thinking that matters most for actual discovery.
Betting blind on AI and the scientific mind
If the struggle to articulate an idea is part of how you come to understand it, then tools that bypass that struggle might degrade your capacity for the kind of thinking that matters most for actual discovery.
By
Tim Requarth
2 February 2026 | 11 min read
PIEZO channels are opening the study of mechanosensation in unexpected places
The force-activated ion channels underlie the senses of touch and proprioception. Now scientists are using them as a tool to explore molecular mechanisms at work in internal organs, including the heart, bladder, uterus and kidney.
PIEZO channels are opening the study of mechanosensation in unexpected places
The force-activated ion channels underlie the senses of touch and proprioception. Now scientists are using them as a tool to explore molecular mechanisms at work in internal organs, including the heart, bladder, uterus and kidney.
By
Calli McMurray
30 January 2026 | 6 min read
Latest iteration of U.S. federal autism committee comes under fire
The new panel “represents a radical departure from all past rosters,” says autism researcher Helen Tager-Flusberg.
Latest iteration of U.S. federal autism committee comes under fire
The new panel “represents a radical departure from all past rosters,” says autism researcher Helen Tager-Flusberg.
By
Angie Voyles Askham
29 January 2026 | 9 min read